Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (781-790 of 1,253) with videos related to

Pageof 126
Sort By:
JAMA|May 29, 2024
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical TrialsLi Shen, Matthew M Y Lee, Pardeep S Jhund, et al.
The American Journal of Medicine|January 25, 2006
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarctionRajendra H Mehta, David Marks, Robert M Califf, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
The American Journal of Medicine|October 24, 2000
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registryM R Shah, C B Granger, B A Bart, et al.
Journal of the American College of Cardiology|January 13, 1998
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary ArteriesE B Sgarbossa, S L Pinski, E J Topol, et al.
Clinical Chemistry|March 25, 1998
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa InvestigatorsR H Christenson, S H Duh, L K Newby, et al.
European Journal of Heart Failure|September 6, 2016
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustmentNathaniel M Hawkins, Pardeep S Jhund, Andrea Pozzi, et al.
American Heart Journal|May 15, 2022
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state modelJulia Aulin, Ziad Hijazi, Johan Lindbäck, et al.
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.
European Journal of Heart Failure|February 13, 2018
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrumLars H Lund, Brian Claggett, Jiankang Liu, et al.
Pageof 126

Showing results (781-790 of 1,253) with videos related to

Sort By:
Pageof 126
JAMA|May 29, 2024
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical TrialsLi Shen, Matthew M Y Lee, Pardeep S Jhund, et al.
The American Journal of Medicine|January 25, 2006
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarctionRajendra H Mehta, David Marks, Robert M Califf, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
The American Journal of Medicine|October 24, 2000
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registryM R Shah, C B Granger, B A Bart, et al.
Journal of the American College of Cardiology|January 13, 1998
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary ArteriesE B Sgarbossa, S L Pinski, E J Topol, et al.
Clinical Chemistry|March 25, 1998
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa InvestigatorsR H Christenson, S H Duh, L K Newby, et al.
European Journal of Heart Failure|September 6, 2016
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustmentNathaniel M Hawkins, Pardeep S Jhund, Andrea Pozzi, et al.
American Heart Journal|May 15, 2022
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state modelJulia Aulin, Ziad Hijazi, Johan Lindbäck, et al.
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.
European Journal of Heart Failure|February 13, 2018
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrumLars H Lund, Brian Claggett, Jiankang Liu, et al.
Pageof 126